Cardiovascular *Temporary Transvenous Pacemakers *Antidysrhythmics *Congestive Heart Failure *Inotropic Agents *Rhythm ...
Specifically, prescriptions for gastrointestinal, cardiovascular and analgesic/anesthetic agents should be carefully evaluated ... cardiovascular (n = 278; 13.9%), and analgesic/anesthetic (n = 74; 13.2%) agents. Issues were resolved on the same day 62% of ... cardiovascular agents (n = 79; 13.9%), and analgesics and anesthetics (n = 74; 13.1%). The most frequent medications recorded ... It was not surprising that the most common reasons for callbacks of antiulcer/dyspepsia agents were regarding prior ...
... posing potential threats to host cardiovascular health. Importantly, oral dysbiosis promotes cardiovascular pathophysiology ... Further extensive efforts are needed to deepen our understanding on oral-cardiovascular connection in the context of diagnostic ... However, targeting oral microbiome might still provide preventive and therapeutic insights on cardiovascular diseases. ... Antimicrobial agents can counteract oral dysbiosis through numerous antimicrobial activities, including the disruption on ...
IBD Biologics, Other Therapies Cleared of Causing Major Adverse Cardiovascular Events * 2002829613-overview ... CBRNE - Biological Warfare Agents * 20021295109-overview. Procedures Skin Grafts and Biologic Skin Substitutes ...
Cardiovascular and Hematological Agents in Medicinal Chemistry *Print: 1871-5257. *Electronic: 1875-6182 ...
Treated hypertension (diagnosis of hypertension and at least one current prescription of at least one antihypertensive agent) ... The age at which the cardiovascular disease risk reaches 50% is the expected age for a cardiovascular event to occur. In this ... We developed the model to estimate the lifetime risk of cardiovascular disease, with death (non-cardiovascular) accounted for ... We identified incident cases of cardiovascular disease based on the first recorded diagnosis of cardiovascular disease recorded ...
Mariinsky Hospital, Regional Cardiovascular Center, Liteyny Ave. 56, 191054, St. Petersburg, Russian Federation ... In order to perform targeted delivery of hemostatic agents further modification of their surface by targeting agents, such as ... Shabanova, E.M., Drozdov, A.S., Fakhardo, A.F. et al. Thrombin@Fe3O4 nanoparticles for use as a hemostatic agent in internal ... Development and assessment of kerateine nanoparticles for use as a hemostatic agent. Materials Science and Engineering: C 63, ...
Cardiovascular toxicity of the first line cancer chemotherapeutic agents: doxorubicin, cyclophosphamide, streptozotocin and ... Cardiovascular toxicity of the first line cancer chemotherapeutic agents: doxorubicin, cyclophosphamide, streptozotocin and ... Antineoplastic Agents:adverse effects, Bevacizumab, Cardiomyopathies:chemically induced, Chemokine CCL2:metabolism, ...
... or within 2 weeks of discontinuation of these agents, because the action of albuterol on the cardiovascular system may be ... Use of Anti-Inflammatory Agents: ProAir Digihaler alone may not be adequate to control asthma in many patients. Early ... Beta-Blockers: Beta-adrenergic-receptor blocking agents not only block the pulmonary effect of beta-agonists, such as ProAir ... Cardiovascular Effects: ProAir Digihaler, like other beta-adrenergic agonists, can produce clinically significant ...
Then we summarized the mechanisms of these alkaloid components of Rhizoma coptidis on cardiovascular and cerebrovascular ... Rhizoma coptidis: a potential cardiovascular protective agent. Front Pharmacol. 2016;7:362. ... It can be employed in infectious diseases, cardiovascular diseases, diabetes and so on. Its new efficacy is also constantly ... Then we summarized the mechanisms of these alkaloid components of Rhizoma coptidis on cardiovascular and cerebrovascular ...
Tilorone, an antiviral agent, can prevent fibrosis in a mouse model of lung disease. We investigated the anti-fibrotic effects ... Cardiac fibrosis is associated with most forms of cardiovascular disease. No reliable therapies targeting cardiac fibrosis are ... Both the agents were able to significantly improve the drying process, without altering the physico-chemical properties of the ... Tilorone, an antiviral agent, can prevent fibrosis in a mouse model of lung [...] Read more. ...
Antimicrobial Agents (22) *Anti-Infectives (12) *Cardiovascular Drugs (6) *Central Nervous System Drugs (7) ...
Cardiovascular Drugs / Antilipemic Agents / HMG-CoA Reductase Inhibitors (i.e. Statins) Cardiovascular Drugs, a-Adrenergic ... Cardiovascular Drugs, Vasodilating Agents Cardiovascular Drugs/Calcium-Channel Blocking Agents Central Nervous System Agents - ... Respiratory Tract Agents, Vasodilating Agents Respiratory Tract Agents: Antifibrotic Agents Respiratory Tract Agents: ... Cardiovascular Drugs, Calcium-Channel Blocking Agents Cardiovascular Drugs, Central a-Agonists Cardiovascular Drugs, Direct ...
C01CA - Adrenergic and dopaminergic agents*C01CA17 - Midodrine *Midodrine ATC Classification , Home Page , Sitemap , Terms & ... C - Cardiovascular system*C01 - Cardiac therapy*C01C - Cardiac stimulants excluding cardiac glycosides* ...
These agents promote anti-inflammatory effects and cause to reduce bad cholesterol in your system, which leads to the risks of ... Lower chances of heart diseases and improved cardiovascular conditions. Polyphenols in white tea enable ones blood vessels to ... White teas health agents prevent and alleviate chronic health conditions, making life better lived and enjoyed with a cup of ... This teas composition provides agents to prevent sicknesses and treat existing health conditions. Get to know more about what ...
Currently, there is no evidence for a preferred antihypertensive agent in IJD disregarding an older report that ACE inhibitors ... Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine 2011;78:179-83. doi:10.1016/ ... Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol 2010;6:445-51. doi:10.1038/nrrheum.2010.105. ... Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann ...
Cardiovascular: Aggravation of angina pectoris, congestive heart failure, prolonged carotid sinus hypersensitivity, orthostatic ... However, significant adverse effects due to Aldomet (methyldopa) have been infrequent and this agent usually is well tolerated. ... Take this quiz and test your IQ of high blood pressure (hypertension), the cardiovascular disease that causes most strokes and ...
Of intrinsic health interest (known cardiovascular agent). Present at high levels in secondhand smoke facilitating easy ... Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence (2010) Chapter: 2 Evaluating Exposure to ... The effect of legislation to ban smoking and its effects on the cardiovascular health of nonsmoking adults, however, remains a ... 4 Epidemiologic Studies of Secondhand-Smoke Exposure and Cardiovascular Disease 95-108 ...
The use of vasoactive agents for people with pulmonary hypertension with left heart disease or hypoxemic lung diseases may ... Cardiovascular risk assessment. Existing cardiovascular disease or a previous cardiovascular event, such as a heart attack or ... Klatsky AL (May 2009). "Alcohol and cardiovascular diseases". Expert Review of Cardiovascular Therapy. 7 (5): 499-506. doi: ... Statins are effective in preventing further cardiovascular disease in people with a history of cardiovascular disease.[159] As ...
Cardiovascular and hematological agents. 2:13-9.. Mayer A.M., and Hamann M.T., (2002) Marine pharmacology in 1999: compounds ... a novel class of anti-inflammatory agents. Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents. 3:271-301. ... Klein L.E., Freeze B.S., Smith A.B. 3rd, and Horwitz S.B., (2005) The microtubule stablizing agent discodermolide is a potent ... Weinheimer A.J., Matson J.A., Hossain, M.B., and Vander H.D., (1977) Marine anticancer agents: Sinularin and dihydrosinularin, ...
Cardiovascular risk factors assessment. Information about smoking status and the use of lipid-lowering agents and ... Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular ... Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004;19:225-30. ... Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management. J Clin Rheumatol 2012;18:422-30. ...
Alternatively, some cardiovascular events may have been a consequence of HIV infection, of antiretroviral therapy, or of a ... 3.7% used lipid lowering agents. Body Mass Index: 4.8% had BMI >30; median BMI was 23.0. 11% had family history of ... However, many of the subjects had cardiovascular risk factors: 56.2 percent were current or previous smokers and 2.8 percent ... Thus, some degree of the cardiovascular risk discussed above may have been the result of predisposing factors, independently of ...
Obesity, metabolic hepatic steatosis (MAFLD) and cardiovascular disease: new metabolic agents and treatment targets.. The ... Obesity, metabolic hepatic steatosis (MAFLD) and cardiovascular disease: new metabolic agents and treatment targets. ... Mortality in NASH is frequently associated with cardiovascular disease and an increased risk of cancer. Therefore, it seems ...
Lantheus Starts Phase I Study for Cardiovascular Agent Using PET. by Lynn Shapiro 09/23/2009 Lantheus Medical Imaging is ... putting its R&D muscle behind contrast agents that work effectively with PET. ...
Medicare is likely to cover cardiovascular screenings and procedures if youve experienced certain conditions. Learn more about ... This is a solicitation of insurance, and your response may generate communication from a licensed producer/agent.. We/Our ... Part B covers cardiovascular screening blood tests every five years. Other preventive measures include cardiovascular disease ... Cardiovascular Procedures Covered Under Medicare. Cardiovascular procedures, such as open heart surgery and heart transplants, ...
33622600 - Beta-blocking agents. 33670000 - Medicinal products for the respiratory system. 33651520 - Immunoglobulins. 33661200 ... 33622000 - Medicinal products for the cardiovascular system. 33731110 - Intraocular lenses. 33610000 - Medicinal products for ... 33621100 - Antithrombotic agents. 33674000 - Cough and cold preparations. 33642100 - Pituitary, hypothalamic hormones and ... 33694000 - Diagnostic agents. 33661000 - Medicinal products for the nervous system. 33662100 - Ophthalmologicals. 33651100 - ...
Novel infectious agent-free hemostatic material (TDM-621) in cardiovascular surgery. Ann Thorac Cardiovasc Surg Methods Enzymol ...
As cardiovascular disease claims more lives than any other disease in America today, grape seed extract may offer much-needed ... Protecting Cardiovascular Health with Whole Grape Extract. Recent studies point to the broad spectrum benefits of whole grape ... Cardiovascular disease involves a cascade of aberrant biological processes, but one area of interest even amongst the medical ... Nowhere are the "blessings of the grape" so evident as in prevention of cardiovascular disease.3 While many factors-ranging ...
Aspirin is an analgesic and antipyretic agent used in the treatment of fever and pain as in arthritis.. It is also associated ... with cardiovascular diseases.. Blocks the production of prostaglandins by inhibiting cyclooxygenase (prostaglandin H synthase ...